Pharmaceutical Contract Manufacturing–our new study reveals trends, R&D progress, and predicted revenues
Where is the Pharmaceutical Contract Manufacturing market heading? If you are involved in this sector you must read this newly updated report. The report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 543 page report provides 700+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Pharmaceutical Contract Manufacturing Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

Product Category

  • Pharmaceutical Product Manufacturing
  • Biological Product Manufacturing

Drug Type

  • API Manufacturing
  • FDF Manufacturing


  • Small Molecule
  • Large Molecule
  • High Potency API (HPAPI)


  • Solid Dose Formulation
  • Liquid Dose Formulation
  • Injectable Dose Formulation
  • Other FDFs

By End-User

  • Big Pharma
  • Small & Mid-size Pharma
  • Generic Pharmaceutical Companies
  • Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

North America

  • U.S.
  • Canada


  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa

  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE
  • Egypt
  • Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the Pharmaceutical Contract Manufacturing Market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Pharmaceutical Contract Manufacturing Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Pharmaceutical Contract Manufacturing Market report helps you
In summary, our 543 page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Pharmaceutical Contract Manufacturing Market, with forecasts for Product Category, Drug Type, API, FDF, and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 16 key national markets – See forecasts for the Pharmaceutical Contract Manufacturing market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 13 of the major companies involved in the Pharmaceutical Contract Manufacturing Market. Some of the company’s profiled in this report include Catalent Inc., Lonza Group AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Mylan NV, AbbVie Inc., Piramal Enterprises Ltd, Consort Medical plc, Baxter International Inc, Alkermes Plc, Bayer AG, GlaxoSmithKline plc, and NIPRO CORPORATION.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.